N. M. Atallah

Combined proliferation and apoptosis index provides better risk stratification in breast cancer

A. Green, E. Rakha, M. Toss, 2023, Histopathology.

Refining the definition of HER2‐low class in invasive breast cancer

G. Ball, A. Green, E. Rakha, 2022, Histopathology.

Differential response of HER2-positive breast cancer to anti-HER2 therapy based on HER2 protein expression level

M. Toss, N. M. Atallah, M. Alsaleem, 2023, British Journal of Cancer.